The clinical performance is complex and often involves multi-system complications. Early identification and standardized clinical treatment are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspections, laboratory tests and pathological checks.
The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the course of the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of HL-related smoking. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.